AI assistant
PFIZER INC — Director's Dealing 2018
Mar 2, 2018
29831_dirs_2018-03-02_048e6c79-1af2-4f24-a0a0-8c096da61c8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2018-02-28
Reporting Person: READ IAN C (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | M | 649780.0000 | $27.3700 | Acquired | 1774184.0000 | Direct |
| 2018-02-28 | Common Stock | F | 104254.0000 | $36.3100 | Disposed | 1669930.0000 | Direct |
| 2018-02-28 | Common Stock | F | 394416.0000 | $35.7000 | Disposed | 1275514.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | Stock Appreciation Rights | $27.3700 | M | 649780.0000 | Disposed | 2018-02-28 | Common Stock (649780.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11073.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.